BioCryst Pharmaceuticals, Inc. Receivables

Receivables of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Receivables growth rates and interactive chart. Accounts receivable (AR) is the balance of money due to a firm for goods or services delivered or used but not yet paid for by customers. Accounts receivables are listed on the balance sheet as a current asset. AR is any amount of money owed by customers for purchases made on credit. When a company makes a sale, it records revenues and a corresponding balance in accounts receivable. When an invoice is paid, the accounts payable account is reduced and cash is received. Receivables should grow in-line with revenue over time, if they are growing much faster, a company might be booking revenue too aggressively.

Highlights and Quick Summary

  • Receivables for the quarter ending September 30, 2022 was $42.6 Million (a 2.7% increase compared to previous quarter)
  • Year-over-year quarterly Receivables increased by 44.87%
  • Annual Receivables for 2021 was $29.4 Million (a 240.19% increase from previous year)
  • Annual Receivables for 2020 was $8.65 Million (a -60.96% decrease from previous year)
  • Annual Receivables for 2019 was $22.1 Million (a 415.86% increase from previous year)
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Receivables of BioCryst Pharmaceuticals, Inc.

Most recent Receivablesof BCRX including historical data for past 10 years.

Interactive Chart of Receivables of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. Receivables for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – $42.61 $41.49 $36.42 –
2021 $29.41 $26.21 $27.62 $18.39 $29.41
2020 $8.65 $5.42 $4.0 $5.64 $8.65
2019 $22.15 $3.6 $3.6 $5.0 $22.15
2018 $4.29 $3.39 $2.34 $5.69 $4.29
2017 $6.12 $8.99 $3.33 $9.56 $6.12
2016 $8.77 $5.97 $2.23 $7.38 $8.77
2015 $6.24 $7.5 $4.3 $5.59 $6.24
2014 $9.49 $3.24 $0.9 $3.28 $9.49
2013 $2.12 $2.37 $1.02 $4.33 $2.12
2012 $4.56 $3.77 $5.08 $5.85 $4.56

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com